Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT01832727 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
65
Enrollment
INDUSTRY
Sponsor class

Stopped Enrollment halted during phase 2 to reformulate the investigational product

Conditions

Interventions

Sponsor

Amgen